Teleflex Incorporated $TFX Shares Acquired by Savant Capital LLC

Savant Capital LLC lifted its position in Teleflex Incorporated (NYSE:TFX) by 81.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,248 shares of the medical technology company’s stock after purchasing an additional 8,166 shares during the period. Savant Capital LLC’s holdings in Teleflex were worth $2,233,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its holdings in Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after buying an additional 77 shares in the last quarter. Hantz Financial Services Inc. grew its position in shares of Teleflex by 248.8% during the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Teleflex in the 3rd quarter valued at about $35,000. Quent Capital LLC acquired a new position in Teleflex in the 3rd quarter worth about $38,000. Finally, True Wealth Design LLC raised its holdings in Teleflex by 10,333.3% in the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock worth $37,000 after purchasing an additional 310 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on TFX. Royal Bank Of Canada reissued a “sector perform” rating and issued a $135.00 price objective on shares of Teleflex in a report on Wednesday, December 17th. Needham & Company LLC raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price target for the company in a report on Tuesday, January 27th. Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Wells Fargo & Company dropped their target price on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 29th. Finally, Truist Financial boosted their target price on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research note on Thursday, December 18th. Two analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $139.00.

Teleflex Trading Up 2.5%

Shares of TFX stock opened at $108.52 on Monday. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $180.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The stock’s fifty day moving average is $115.18 and its two-hundred day moving average is $119.35. The firm has a market capitalization of $4.80 billion, a P/E ratio of -14.76, a PEG ratio of 1.41 and a beta of 0.92.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. The business had revenue of $892.90 million during the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The company’s quarterly revenue was up 19.4% compared to the same quarter last year. During the same period in the prior year, the business earned $3.49 earnings per share. Research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.